Cravath Swaine & Moore represented Ashland Inc. in the transaction. Ashland Inc. (NYSE: ASH) announced that it has signed a definitive agreement to sell its nutraceuticals...
Turnspire Capital Partners’ Acquisition of Ashland’s Nutraceuticals Business
TowerBrook Capital Partners’ Acquisition of IT Solutions Provider CBTS
Sidley Austin LLP represented TowerBrook Capital Partners L.P. on the transaction, and Cravath Swaine & Moore represented altafiber. TowerBrook Capital Partners (“TowerBrook”) annoubnced the acquisition of...
Star Bulk’s $2.1 Billion Merger with Eagle Bulk Shipping
Cravath, Swaine & Moore is representing Star Bulk Carriers Corp. in the transaction, and Akin Gump Strauss Hauer & Feld is representing Eagle Bulk Shipping. Star...
Radius Pharmaceuticals’ Royalty Purchase Agreement with DRI Healthcare
Ropes & Gray and Kirkland & Ellis acted as legal advisors to Radius. Cravath, Swaine & Moore acted as legal advisor to DRI Healthcare. Radius Pharmaceuticals,...
Biogen’s $7.3 Billion Acquisition of Reata Pharmaceuticals
Cravath acted as legal advisor to Biogen, Vinson & Elkins acted as legal advisor to Reata, and Skadden advised Goldman Sachs. Biogen Inc. (Nasdaq: BIIB) and...
RedHill’s Agreement with HealthCare Royalty to Extinguish Debt Obligations in Exchange for Movantik
Cravath represented RedHill in connection with the transaction. RedHill Biopharma Ltd. (“RedHill”), a specialty biopharmaceutical company, announced the extinguishment of all RedHill’s debt obligations (including all...
Cameco and Brookfield Renewable Partners’ Acquisition of Westinghouse Electric Company
Cravath represented Brookfield Renewable, Covington, Conyers, Vinge and Loyens & Loeff advised Cameco Corporation, Skadden represented Goldman Sachs the financial advisor in the transaction. Cameco Corporation...